Skip to main content

Proceeding contribution from Mark Simmonds (Conservative) in the House of Commons on Wednesday, 22 October 2008. It occurred during Debate on bill on Human Fertilisation and Embryology Bill [Lords].


Human Fertilisation and Embryology Bill [Lords]

The Bill is of great significance. It has tried to strike a balance—to allow scientific advancement while being based on an ethical platform. It is a shame in some ways that it has had this unfortunate end. Clearly, there are many dissatisfied Members in the House, and that is primarily due to the programme motion, which has not allowed important amendments and issues to be debated. Conservative Members had a free vote on the Bill, and in my view there should have been far more free votes for Government Members, too. We are talking about significant ethical and moral issues, and Members should be allowed to vote with their conscience. However, the Minister and the Government have listened to some of the suggestions made, for example on licences for therapy, on consent issues relating to pre-existing cell lines, on regulations on the appeal procedures and on changes to surrogacy laws. There have been constructive debates on the Floor of the House and in Committee. I thank my hon. Friends the Members for South-West Devon (Mr. Streeter), for Hemel Hempstead (Mike Penning), for Rugby and Kenilworth (Jeremy Wright) and for Salisbury (Robert Key) for making constructive contributions as the Bill passed through the House. It is important to understand that the Human Fertilisation and Embryology Act 1990—an extremely robust piece of legislation—retains much of its significance and value because it was thoroughly debated in this House and in the other place. It was originally the Minister's hope, and it is my hope, that this Bill will be similarly enduring. However, after today's performance, I have to question whether it will be. I hope that the shape of the ethical and regulatory framework for reproductive science and medicine will hold for many years to come. The Bill is built on a moral and ethical regulatory framework that will allow Britain to remain at the forefront of scientific and medical innovation while, importantly, still protecting the special status of the embryo.


Secondary information

Type
Proceeding contribution
Reference
481 c409-10 
Session
2007-08
Chamber / Committee
House of Commons chamber
Subjects
Civil partnerships Clones Animals Abortion Congenital abnormalities Fertility Licensing Human embryo experiments Diseases Donors Genetics Human Fertilisation and Embryology Authority Ethics IVF Fathers Medical treatments Northern Ireland Parents Mental capacity Screening Research Surrogacy Human-animal hybrid embryos
Legislation
Human Fertilisation and Embryology Bill (HL) 2007-08
Link
View this Proceeding contribution on www.publications.parliament.uk